Wealthcare Advisory Partners LLC cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 6.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,588 shares of the exchange traded fund’s stock after selling 299 shares during the quarter. Wealthcare Advisory Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $413,000 at the end of the most recent quarter.
Other large investors also recently added to or reduced their stakes in the company. Tidemark LLC boosted its position in SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares during the period. Quintet Private Bank Europe S.A. acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth $40,000. ORG Wealth Partners LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth $44,000. Howe & Rusling Inc. bought a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $49,000. Finally, Waldron Private Wealth LLC bought a new position in SPDR S&P Biotech ETF in the 3rd quarter worth $54,000.
SPDR S&P Biotech ETF Price Performance
SPDR S&P Biotech ETF stock opened at $87.97 on Tuesday. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The firm has a fifty day moving average price of $93.78 and a two-hundred day moving average price of $96.96. The firm has a market cap of $6.71 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Investing in Construction Stocks
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.